Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (261-270 of 652) with videos related to

Pageof 66
Sort By:
Vascular Pharmacology|August 25, 2020
Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolismMichał Ząbczyk, Joanna Natorska, Krzysztof P Malinowski, et al.
Biochemical and Biophysical Research Communications|October 27, 2019
Identification of glycated and acetylated lysine residues in human α2-antiplasminAgata Hanna Bryk, Dominik Cysewski, Michał Dadlez, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 5, 2005
Phlegmasia cerulea dolens as a complication of deep vein thrombosis in a man with primary antiphospholipid syndromeAgnieszka Padjas, Beata Brzezinska-Kolarz, Anetta Undas, et al.
Journal of Cardiology|August 30, 2014
Exercise stress testing enhances blood coagulation and impairs fibrinolysis in asymptomatic aortic valve stenosisRenata Kolasa-Trela, Korneliusz Fil, Ewa Wypasek, et al.
International Journal of Hematology|January 5, 2021
Correction to: Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort studyJoanna Zuk, Elzbieta Papuga-Szela, Lech Zareba, et al.
Journal of Cardiovascular Pharmacology|July 29, 2021
Nonvitamin K Antagonist Oral Anticoagulant in Patients With Venous Thromboembolism and Polycythemia Vera or Essential Thrombocythemia: A Cohort StudyAnna Weronska, Elżbieta Papuga-Szela, Elzbieta Broniatowska, et al.
Vascular Pharmacology|November 21, 2016
Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolismAgata Hanna Bryk, Magdalena Piróg, Krzysztof Plens, et al.
Thrombosis Research|July 6, 2012
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoformAnetta Undas, Mariola Cieśla-Dul, Tomasz Drążkiewicz, et al.
Polish Archives of Internal Medicine|May 17, 2018
Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experienceTadeusz Góralczyk, Elżbieta Papuga-Szela, Joanna Żuk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|November 5, 2021
Caprini VTE computerized risk assessment improves the use of thromboprophylaxis in hospitalized patients with pulmonary disordersRobert Franciszek Łukaszuk, Krzysztof Piotr Nycz, Krzysztof Plens, et al.
Pageof 66

Showing results (261-270 of 652) with videos related to

Sort By:
Pageof 66
Vascular Pharmacology|August 25, 2020
Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolismMichał Ząbczyk, Joanna Natorska, Krzysztof P Malinowski, et al.
Biochemical and Biophysical Research Communications|October 27, 2019
Identification of glycated and acetylated lysine residues in human α2-antiplasminAgata Hanna Bryk, Dominik Cysewski, Michał Dadlez, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 5, 2005
Phlegmasia cerulea dolens as a complication of deep vein thrombosis in a man with primary antiphospholipid syndromeAgnieszka Padjas, Beata Brzezinska-Kolarz, Anetta Undas, et al.
Journal of Cardiology|August 30, 2014
Exercise stress testing enhances blood coagulation and impairs fibrinolysis in asymptomatic aortic valve stenosisRenata Kolasa-Trela, Korneliusz Fil, Ewa Wypasek, et al.
International Journal of Hematology|January 5, 2021
Correction to: Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort studyJoanna Zuk, Elzbieta Papuga-Szela, Lech Zareba, et al.
Journal of Cardiovascular Pharmacology|July 29, 2021
Nonvitamin K Antagonist Oral Anticoagulant in Patients With Venous Thromboembolism and Polycythemia Vera or Essential Thrombocythemia: A Cohort StudyAnna Weronska, Elżbieta Papuga-Szela, Elzbieta Broniatowska, et al.
Vascular Pharmacology|November 21, 2016
Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolismAgata Hanna Bryk, Magdalena Piróg, Krzysztof Plens, et al.
Thrombosis Research|July 6, 2012
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoformAnetta Undas, Mariola Cieśla-Dul, Tomasz Drążkiewicz, et al.
Polish Archives of Internal Medicine|May 17, 2018
Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experienceTadeusz Góralczyk, Elżbieta Papuga-Szela, Joanna Żuk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|November 5, 2021
Caprini VTE computerized risk assessment improves the use of thromboprophylaxis in hospitalized patients with pulmonary disordersRobert Franciszek Łukaszuk, Krzysztof Piotr Nycz, Krzysztof Plens, et al.
Pageof 66